Clinical Validation of the Blood Pressure Measuring Device Withings BPM Pro 2 (WIHYP-GP)

NCT ID: NCT06957847

Last Updated: 2025-05-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-28

Study Completion Date

2025-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to assess the accuracy of the automatic oscillometric BP measuring device at the brachial level, the WITHINGS BPM Pro 2, in the general population

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DEVICE_FEASIBILITY

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

All patients

Patients consenting to participate to the study and compliant to the inclusion criteria

Group Type EXPERIMENTAL

Blood pressure measurement

Intervention Type DEVICE

The patient will be measured alternatively with a reference mercury sphygmomanometer (four times) and the device under study (3 times)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood pressure measurement

The patient will be measured alternatively with a reference mercury sphygmomanometer (four times) and the device under study (3 times)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient older than 18 years;
* Patient who signed the informed consent form;
* Patient followed-up at site (in-patient or out-patient);
* Patient with arm circumference between 22 cm and 42 cm.

Exclusion Criteria

* Patient unable to give a consent or understand properly protocol information;
* Patient suffering from arrhythmia;
* Patient with poor quality of Korotkov sounds;
* Patient for whom K5 sounds are absent;
* Patient wearing an implantable electric medical device (pacemaker,…);
* Patient with both upper arms suffering from open wound and/or damaged skin.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Withings

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

N2

Yerevan, , Armenia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Armenia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ruiyi Yang, PhD

Role: CONTACT

+33 1.41.46.04.60 ext. +33 1.41.46.04

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Parounak ZELVEIAN, Professor

Role: primary

+374-10-530572

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2025-A00050-49

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Valid-B.Well BP25 Study
NCT07340957 NOT_YET_RECRUITING NA